Amrize Ltd
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $11.82B | $11.70B | $11.68B |
| Cost of Revenue | $8.78B | $8.63B | $8.91B |
| Gross Profit | $3.03B | $3.07B | $2.77B |
| Gross Margin | 25.7% | 26.2% | 23.7% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $1.13B | $944.0M | $898.0M |
| Operating Income | $1.91B | $2.20B | $1.89B |
| Operating Margin | 16.1% | 18.8% | 16.2% |
| Interest Expense | $216.0M | $43.0M | $49.0M |
| Pretax Income | $1.50B | $1.63B | $1.30B |
| Income Tax Expense | $326.0M | $368.0M | $361.0M |
| Net Income | $1.19B | $1.27B | $956.0M |
| Net Margin | 10.0% | 10.9% | 8.2% |
| EPS (Basic) | $2.14 | $2.30 | $1.73 |
| EPS (Diluted) | $2.14 | $2.30 | $1.73 |
| Shares Outstanding (Basic) | 553.1M | 553.1M | 553.1M |
| Shares Outstanding (Diluted) | 553.6M | 553.1M | 553.1M |
| Dividends Per Share | — | — | — |